4D Molecular Therapeutics, Inc. (FDMT)
9.72
-0.19
(-1.92%)
USD |
NASDAQ |
Jun 01, 16:00
9.71
-0.01
(-0.10%)
After-Hours: 20:00
4D Molecular Therapeutics EPS Diluted (Quarterly) : -1.010 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.2528 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -68.76M |
| Revenue (Quarterly) | 3.047M |
| Total Expenses (Quarterly) | 71.81M |
| Enterprise Value | 147.70M |
| Gross Profit Margin (Quarterly) | 32.56% |
| Profit Margin (Quarterly) | -2.26K% |
| Earnings Yield | -27.41% |
| Normalized Earnings Yield | -27.40 |